FLINT, Mich., April 12, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has been selected to provide pharmacy services and dispense limited-distribution specialty drugs for Corizon Health's clients and support its in-house mail-order pharmacy, PharmaCorr.
The three-year agreement, effective March 17, 2017, supports specialty pharmacy services for 321,000 patients across 25 states.
Corizon Health, based in Brentwood, Tennessee, is the nation's leader in correctional health care, providing high-quality services to 50 clients at 431 facilities across the country.
Diplomat will serve Corizon Health patients, filling prescriptions for limited-distribution drugs and other specialty drugs. PharmaCorr currently fills an average of 20,000 prescriptions per day. Diplomat will be one of two partner pharmacies supporting Corizon Health's network.
"We are constantly striving to enhance the quality of the health care we deliver, always mindful of safety, efficiency, and cost-effectiveness," said Mark Moyers, RPh, director of clinical pharmacy services for Corizon Health. "Diplomat's commitment to provide optimized care—ensuring appropriate use, minimizing waste, and supporting client adherence—will build upon Corizon Health's dedication to the client experience."
Diplomat has extensive experience working with payors—including commercial, Medicare, Medicaid, government, and employer groups—and serves more than 3,000 different accounts as a specialty pharmacy, representing access to approximately 194 million lives.
"At Diplomat, we help take care of the nation's sickest patients—a responsibility we don't take lightly. We are proud to extend our services through our partnership with Corizon Health," said Atheer Kaddis, executive vice president of sales and strategic alignment at Diplomat. "As part of Corizon Health's network, we will use our experience and resources to provide support services to each clients' unique needs."
To learn more about Diplomat, visit diplomat.is.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management's good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat's filings with the Securities and Exchange Commission, including "Risk Factors" in Diplomat's Annual Report on Form 10-K for the year ended Dec. 31, 2016, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments or otherwise.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: "Take good care of patients and the rest falls into place." Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
About Corizon Health
Corizon Health, a member of the Valitas Health Services corporate family, provides quality health care services to states and municipalities across the country offering the only comprehensive solution for physical care, behavioral care, and pharmaceutical services. With its corporate headquarters in Brentwood, Tennessee, Corizon Health is the leading provider of correctional services in the United States. For more information, please visit corizonhealth.com.
Kali Lucas, Public Relations Specialist
810.768.9580 | email@example.com
Atheer Kaddis, Executive Vice President,
Sales and Strategic Alignment
810.768.9519 | firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/diplomat-partners-with-corizon-health-to-dispense-specialty-drugs-300438945.html
SOURCE Diplomat Pharmacy, Inc.